Dr. Parissa Farnia is the Director of the Iranian National Reference Tuberculosis Laboratory (INRT) at the Mycobacteriology Research Center (MRC) in the National Research Institute of Tuberculosis and Lung Disease (NRITLD). Her expertise and research interests include mycobacteriology, infectious diseases, and tuberculosis. She has published in multiple international journals such as Journal of Clinical Microbiology, Chest, Clinical infectious Diseases, and the International Journal of Tuberculosis and Lung Disease and serves on several editorial boards including International Journal of Mycobacteriology, the Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, and the Biomedical and Biotechnology Research Journal. Dr. Ali Akbar Velayati is the Director of the National Research Institute of Tuberculosis and Lung Diseases (NRITLD) at the Shahid Beheshti University of Medical Sciences. He is a Full Professor of Pediatric Infectious Diseases, and he has guided more than 300 MD and PhD students. He is also the Head of Mycobacteriology Research Center (MRC) in NRITLD, where he directly monitors the basic and clinical trial on tuberculosis. Dr. Velayati is the President of the Asian African Society of Mycobacteriology and of the Society of Biomedical and Biotechnology Scientists. He is the Chief Editor of the International Journal of Mycobacteriology, the Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, and the Biomedical and Biotechnology Research Journal. Poopak Farnia is currently an Associate Professor in the Biotechnology, Tissue Engineering and Stem Cells Unit of the Mycobacteriology Research Center at the National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences in Tehran, Iran. Jalaledin Ghanavi, MD, is surgeon, an Associate Professor, and the Head of the Department of Tissue Engineering and Experimental Medicine in the Mycobacteriology Research Center at the National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences in Tehran, Iran. He received the MD degree from the Isfahan University of Medical Science and has medical expertise in general medicine and general surgery. His ongoing research interests include tissue engineering, nanoarchitectonics, biomedicine, and nanomedicine, and he holds five U.S patents.

Select Guide Rating

• 1. Introduction to Nontuberculous Mycobacterium (NTM)2. Key Structural Features of NTM Proteins3. Pathogenic Mechanisms of Nontuberculous Mycobacteria4. Virulence Factors of Nontuberculous Mycobacterium5. Antibiotic Resistance in Nontuberculous Mycobacteria6. Future Directions and Emerging Research in Nontuberculous Mycobacteria7. Perspectives on the Future of Treatment and Prevention Strategies

Dr. Parissa Farnia is the Director of the Iranian National Reference Tuberculosis Laboratory (INRT) at the Mycobacteriology Research Center (MRC) in the National Research Institute of Tuberculosis and Lung Disease (NRITLD). Her expertise and research interests include mycobacteriology, infectious diseases, and tuberculosis. She has published in multiple international journals such as Journal of Clinical Microbiology, Chest, Clinical infectious Diseases, and the International Journal of Tuberculosis and Lung Disease and serves on several editorial boards including International Journal of Mycobacteriology, the Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, and the Biomedical and Biotechnology Research Journal. Dr. Ali Akbar Velayati is the Director of the National Research Institute of Tuberculosis and Lung Diseases (NRITLD) at the Shahid Beheshti University of Medical Sciences. He is a Full Professor of Pediatric Infectious Diseases, and he has guided more than 300 MD and PhD students. He is also the Head of Mycobacteriology Research Center (MRC) in NRITLD, where he directly monitors the basic and clinical trial on tuberculosis. Dr. Velayati is the President of the Asian African Society of Mycobacteriology and of the Society of Biomedical and Biotechnology Scientists. He is the Chief Editor of the International Journal of Mycobacteriology, the Journal of Preventive, Diagnostic and Treatment Strategies in Medicine, and the Biomedical and Biotechnology Research Journal. Poopak Farnia is currently an Associate Professor in the Biotechnology, Tissue Engineering and Stem Cells Unit of the Mycobacteriology Research Center at the National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences in Tehran, Iran. Jalaledin Ghanavi, MD, is surgeon, an Associate Professor, and the Head of the Department of Tissue Engineering and Experimental Medicine in the Mycobacteriology Research Center at the National Research Institute of Tuberculosis and Lung Disease, Shahid Beheshti University of Medical Sciences in Tehran, Iran. He received the MD degree from the Isfahan University of Medical Science and has medical expertise in general medicine and general surgery. His ongoing research interests include tissue engineering, nanoarchitectonics, biomedicine, and nanomedicine, and he holds five U.S patents.

Select Guide Rating

• 1. Introduction to Nontuberculous Mycobacterium (NTM)2. Key Structural Features of NTM Proteins3. Pathogenic Mechanisms of Nontuberculous Mycobacteria4. Virulence Factors of Nontuberculous Mycobacterium5. Antibiotic Resistance in Nontuberculous Mycobacteria6. Future Directions and Emerging Research in Nontuberculous Mycobacteria7. Perspectives on the Future of Treatment and Prevention Strategies